Prelim data probably wont be coming this year, only 2 weeks left in December, take in holidays, new years, the fact that it usually takes 2 months at the lower end to get prelim data out to market, looking at early 2025, seems like the market doesnt care too much about the finish of study (less than $3000 dollars trading off this announcement) need some results to get some positive price action.
Ann: Phase 1B CHM CORE-NK trial advances to newly diagnosed AML, page-7
Add to My Watchlist
What is My Watchlist?
